ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
6
views
0
references
Top references
cited by
11
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,276
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
BCG vaccination in South African HIV-exposed infants--risks and benefits.
Author(s):
A Hesseling
,
J. Caldwell
,
M Cotton
,
B S Eley
,
H Jaspan
,
K. Jennings
,
B J Marais
,
J. NUTTALL
,
H Rabie
,
P. Roux
,
H Schaaf
Publication date:
2009-01-31
Journal:
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
Keywords:
Adjuvants, Immunologic
,
contraindications
,
standards
,
BCG Vaccine
,
Drug Administration Schedule
,
HIV Infections
,
complications
,
drug therapy
,
transmission
,
HIV Seronegativity
,
immunology
,
Health Policy
,
Humans
,
Infant
,
Infant, Newborn
,
Infectious Disease Transmission, Vertical
,
Risk Assessment
,
South Africa
,
Tuberculosis
,
prevention & control
Read this article at
ScienceOpen
PMC
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
ChemSpider related publications
Author and article information
Journal
PubMed ID::
19418667
PMC ID::
2869300
ScienceOpen disciplines:
Chemistry
Keywords:
Adjuvants, Immunologic
,
contraindications
,
standards
,
BCG Vaccine
,
Drug Administration Schedule
,
HIV Infections
,
complications
,
drug therapy
,
transmission
,
HIV Seronegativity
,
immunology
,
Health Policy
,
Humans
,
Infant
,
Infant, Newborn
,
Infectious Disease Transmission, Vertical
,
Risk Assessment
,
South Africa
,
Tuberculosis
,
prevention & control
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adjuvants, Immunologic
,
contraindications
,
standards
,
BCG Vaccine
,
Drug Administration Schedule
,
HIV Infections
,
complications
,
drug therapy
,
transmission
,
HIV Seronegativity
,
immunology
,
Health Policy
,
Humans
,
Infant
,
Infant, Newborn
,
Infectious Disease Transmission, Vertical
,
Risk Assessment
,
South Africa
,
Tuberculosis
,
prevention & control
Comments
Comment on this article
Sign in to comment
Similar content
1,276
Checkpoint inhibitors in BCG-unresponsive nonmuscle invasive bladder cancer: can they help spare the bladder?
Authors:
Khalil El Gharib
,
Eddy Lilly
,
Roy Chebel
Cloning, sequencing, and localization of an ovine fragment of the NRAMP gene, a candidate for the ITY/LSH/BCG gene.
Authors:
F Pitel
,
I Lantier
,
J. RIQUET
…
A 2-Dose AERAS-402 Regimen Boosts CD8
+
Polyfunctionality in HIV-Negative, BCG-Vaccinated Recipients
Authors:
Dhanasekaran Sivakumaran
,
Gretta Blatner
,
Rasmus Bakken
…
See all similar
Cited by
11
Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial
Authors:
Caryn Upton
,
Rob van Wijk
,
Laurynas Mockeliunas
…
In silico Analysis and Experimental Validation of Mycobacterium tuberculosis -Specific Proteins and Peptides of Mycobacterium tuberculosis for Immunological Diagnosis and Vaccine Development
Authors:
Abu Salim Mustafa
Getting to 90-90-90 in paediatric HIV: What is needed?
Authors:
Mary-Ann Davies
,
Jorge Pinto
,
Marlene Bras
…
See all cited by
Version 1
Version 1